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Heart failure is the common final pathway of several cardiovascular conditions and a
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major cause of morbidity and mortality worldwide. Aberrant activation of the adaptive immune system in response to myocardial necrosis has recently been implicated
in the development of heart failure. The ß-adrenergic agonist isoproterenol hydro-
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chloride is used for its cardiac effects in a variety of different dosing regimens with
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induced cardiomyocyte necrosis triggers an adaptive immune response against the
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by the activation of T cells, the presence of anti-heart auto-antibodies in the serum as

high doses causing acute cardiomyocyte necrosis. To assess whether isoproterenolheart, we treated C57BL/6J mice with a single intraperitoneal injection of isoproterenol. We confirmed tissue damage reminiscent of human type 2 myocardial infarction.
This is followed by an adaptive immune response targeting the heart as demonstrated
late as 12 weeks after initial challenge and IgG deposition in the myocardium. All of
these are hallmark signs of an established autoimmune response. Adoptive transfer
of splenocytes from isoproterenol-treated mice induces left ventricular dilation and
impairs cardiac function in healthy recipients. In summary, a single administration of
a high dose of isoproterenol is a suitable high-throughput model for future studies
of the pathological mechanisms of anti-heart autoimmunity and to test potential immunomodulatory therapeutic approaches.
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1 | I NTRO D U C TI O N

activation and replacement fibrosis. We show that this cardiac injury
activates CD4+ helper T cells and subsequently induces persistent

Type 2 myocardial infarction (T2MI) is a heterogeneous syndrome

IgG+ anti-heart auto-antibody production. A single high dose of iso-

resulting in ischaemic damage to the heart because of insufficient

proterenol is therefore a simple, resource-efficient and minimally

myocardial oxygen supply.1,2 Unlike type 1 MI (T1MI), T2MI occurs in

invasive model of T2MI to investigate the role of post-MI anti-heart

the absence of coronary artery disease (CAD) or the disruption of an

autoimmunity.

atherosclerotic plaque. Instead, other conditions including hypoxaemia, hypo/hypertension, tachycardia or tachyarrhythmias lead to an
imbalance between myocardial oxygen supply and demand, culminating in cardiomyocyte necrosis.

3,4

2 | M ATE R I A L S A N D M E TH O DS

Importantly, T2MI is still an un-

der-recognised clinical entity, despite a recent estimate that 58% of

Mice: All animal procedures carried out at Imperial College London

total MI patients in fact suffer from T2MI.5 The development of high

were approved by the Imperial College Governance Board for Animal

sensitivity biomarker assays for cardiac troponin I, which allow the

Research and in accordance with the UK Home Office Animals

detection of even mildly elevated levels of cardiac troponin in the

(Scientific Procedures) Act 1986 and Directive 2010/63/EU of the

absence of CAD or a T1MI diagnosis, has made the discrimination

European Parliament on the protection of animals used for scientific

between T1MI and T2MI possible.6 T2MI patients face poor short-

purposes. All animal works carried out at The Jackson Laboratories

and long-term outcomes and a heart failure risk equal to T1MI.7,8

were approved by The Jackson Laboratory Institutional Animal Care

Heart failure, the final common pathway of a range of cardiovascular

and Use Committee and were in accordance with national and inter-

conditions, affects up to 62.7% of MI patients within 6 years after

national regulations. Mice used were 8- to 12-week-old male or fe-

infarction.9

male C57BL/6J mice; within each experiment, experimental groups

Myocardial necrosis triggers an immediate response by the

were age- and sex-matched. Mice were purchased from Charles

10

innate immune system which is crucial for quick tissue repair.

River UK (Imperial College London) or bred in house (The Jackson

However, excessive inflammation is a potent pathological factor in

Laboratories). After random allocation to experimental groups, mice

heart failure and has been studied extensively.11–13 Recently, it has

were housed under SPF conditions (Imperial College London) or in

also been suggested that the adaptive immune system is activated

conventional cages (The Jackson Laboratories) in temperature-con-

after MI and may play a role in the deterioration of heart function

trolled facilities on a 12-h light/dark cycle on standard diet.

and the development towards heart failure.14–17 However, patholog-

Isoproterenol treatment and tissue harvest: Mice were treated

ical mechanisms are far from understanding and there is an urgent

with isoproterenol HCL (Sigma-Aldrich, St. Louis, MO, USA) in

need for better recognition and understanding of these immunolog-

Dulbecco's phosphate-buffered saline (DPBS; Sigma-Aldrich) by a

ical processes, if they are to become the target of future therapeutic

single intraperitoneal injection of 160 mg/kg. Control mice were

applications.

treated with DPBS at equivalent volume. On the day of tissue col-

Investigation of the adaptive immune response to cardiac

lection, 200 μl blood was collected. Blood was incubated on ice for

damage is highly complex and still relies heavily on in vivo ex-

30 minutes and then centrifuged for 3 minutes at max rcf for serum

perimentation. In rodents, surgical coronary artery ligation of

collection. Organs were isolated after in situ perfusion with ice-cold

the left anterior descending artery (LAD) is the most commonly

DPBS supplemented with 0.9 mM CaCl2 through the apex of the left

used experimental model for human T1MI,18 whereas a dedicated
model for T2MI is missing. The use of the ß-adrenergic agonist isoproterenol to induce cardiomyocyte necrosis has been described
19,20

ventricle of the heart to clear blood from heart chambers and blood
vessels.
Adoptive transfer: Donor mice were treated with isoprotere-

and has been characterised exten-

nol HCL (Sigma-Aldrich, St. Louis, MO, USA) in DPBS by a single

sively. 21,22 It now routinely serves as a long-term low-dose treat-

intraperitoneal injection of 160 mg/kg. 4 weeks after isoprotere-

ment to induce cardiac hypertrophy, 23–25 and few research groups

nol injection, serum and spleens were harvested. Excised spleens

have also used it to induce acute infarct-like necrotic lesions by

were mashed through a 70μm cell strainer to generate single-cell

injection of high doses. 26–28 Importantly, the isoproterenol model

suspensions, followed by red blood cell lysis using Red Blood Cell

recapitulates several of the salient features of T2MI. The acute

Lysis Buffer (Sigma-Aldrich, St. Louis, MO, USA). CD4+ T cells

ß-adrenergic activation has a strong positive inotropic and chro-

were enriched using the EasySep™ Mouse CD4+ T Cell Isolation

over 50 years ago in rats

notropic effect,

29

leading to increased oxygen demand, dysregu-

Kit (STEMCELL Technologies, Cambridge, UK) as per the manufac-

lation of ryanodine receptor 2 (RyR2) and consequent intracellular

turer's instructions. Recipient mice were pre-treated 24h before

calcium leakage. 27 These are all factors that contribute to cardio-

adoptive transfer with a single topical application to the right ear

myocytes necrosis and acute myocardial injury.

of 3.3μg/μl/g bodyweight (in 1:3 ethanol:acetone) of Resiquimod

Here, we characterise the effects of a single high dose of

(Sigma-Aldrich, Dorset, UK). Recipients received a single intrave-

isoproterenol on the adaptive immune response to ischaemic

nous injection of either PBS, 3x107 control splenocytes, 3x107

myocardial damage in C57BL/6J mice. We confirm that isoprotere-

isoproterenol splenocytes, 1x107 CD4+ T cells or twice-weekly in-

nol-induced myocardial necrosis is severe enough to trigger immune

traperitoneal injection of 200ul isoproterenol serum for 2 weeks,

|
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respectively. Pathological effects of adoptive transfers were ana-

Jose, CA, US) and the public domain software ImageJ (NIH; http://

lysed after 4 weeks.

rsb.info.nih.gov).31

Cardiac magnetic resonance imaging (MRI): Longitudinal car-

Cardiac troponin I and anti-heart auto-antibody ELISA: A mouse

diac MRI was performed before and 2 weeks post-isoprotere-

cardiac troponin I (cTnI) ELISA Kit (MyBioSource, San Diego, CA, USA)

nol injection. Mice were anaesthetised with 1%-2.5% isoflurane

was used to determine cTnI concentrations in post-isoproterenol

adjusted to maintain the respiratory rate of 65-75 breaths/min.

serum as instructed by the manufacturer. Serum samples were diluted

Body temperature was maintained at 37 ± 0.5°C by a heating mat.

two-fold in supplied diluent. A standard curve was generated to cal-

Respiration, ECG and body temperature were continuously moni-

culate cTnI concentrations in pg/ml. The ELISA protocol for the detec-

tored (SA Instruments, Stony Brook, NY, USA). MRI was performed

tion of mouse anti-heart auto-antibodies was optimised as described

on a 9.4 T-BioSpec system (Bruker BioSpin, Ettlingen, Germany)

previously.30 ELISA plates (SpectraMax Paradigm, Molecular Devices,

equipped with a mouse heart array receiver. For localisation of

UK) were coated with 50µl per well of 4µg/µl pig heart lysate (Novus

the heart, low-resolution ECG and respiratory triggered gradi-

Biologicals, Bio-Techne, Abingdon, UK) diluted in PBS overnight at 4

ent-echo scout scans were initially acquired in axial, sagittal and

ºC. Plates were washed 3 times for 5 minutes each with 200 µl per well

coronal orientations followed by highly resolved vertical long-axis

of ELISA washing buffer. 50 µl of post-isoproterenol serum was added

(VLA) and horizontal long-axis (HLA) views. Ejection fraction (EF),

diluted 1:10 and 1:100 for overnight incubation at 4 ºC. Detection re-

end-diastolic volume (EDV), end-systolic volume (ESV) and mass

agents were anti-mouse IgG-HRP (all from BioLegend, London, UK).

were quantified from a multi-slice multi-frame CINE sequence

Optical densities were measured at 450 nm using a SpectraMAX i3

with slices oriented in short axis covering the entire left ventri-

Microplate Reader (Molecular Devices, San Jose, CA, USA).

cle (LV), making sure to include the mitral annulus and the apex.

Heart and lymph node single-cell preparation: To generate sin-

Acquisition parameters are as follows: repetition time (TR)=RR

gle-cell cardiac suspensions for flow cytometry, a modified digestion

interval/number of frames (∼10 ms for 11 frames), TReffective = RR

protocol was used as previously described.32 Hearts were excised,

interval, echo time (TE) = 2.05 ms, flip angle = 25°, slice thick-

chopped 30 times with surgical scissors and placed in 3 ml digestion

ness = 1 mm (continuous slices), acquisition matrix = 122 × 122

buffer. The digestion buffer consisted of 2 mg/ml collagenase type IV

and field of view = 20 × 20 mm2 , leading to a spatial in-plane res-

olution of 164 × 164 μm2 .

(Worthington Biochemical Corporation, Lakewood, NJ, USA), 1.2 U/
ml dispase II (Thermo Fisher Scientific, Waltham, MA, USA) and 16.6

Echocardiography: The high-frequency ultrasound system Vevo

ul/ml precision count beads (BioLegend, San Diego, CA, USA) in DPBS

770 (VisualSonics Inc, Toronto, Canada) with a 30-MHz linear trans-

supplemented with 0.9 mM CaCl2. The tissue was incubated at 37ºC

ducer was used for transthoracic echocardiography. Anaesthesia

for 15 minutes. After incubation, tissue was triturated 12 times. Tissue

was induced at 1%-2% isoflurane, and warmed ultrasound gel and a

was incubated and triturated 2 more times for a total of 45 minutes.

heating pad were used to maintain body temperature at 37 ± 0.5°C

The final trituration was increased to 30. Tissue was filtered through

and heart rate at 450 ± 50 beats per minute. Left ventricular (LV)

sterile cheesecloth and washed with ice-cold DPBS supplemented

parameters were calculated from M-mode traces at base, mid-level

with 0.9 mM CaCl2 for 20 minutes at 200 rcf at 4 ºC. Lymph nodes

and apex in parasternal long- and short-axis views. Analysis was per-

were incubated at 37ºC for 30 minutes in 3 ml and 0.5 ml digestion

formed using the Vevo 770 workstation software.

buffer, respectively. Lymphoid digestion buffer consisted of 0.24 U/mg

Histology and scoring of damage parameters: Organs were ex-

400 Mandl U/ml collagenase D (Roche Diagnostics GmbH Mannheim,

cised as described above, fixed in 10% neutral buffered formalin

Germany) in FBS-free DMEM. Cells were washed twice in FACS buffer

overnight and stored in 70% ethanol. For wax-embedding and his-

supplemented with 2% FBS spun for 5 minutes at 400 rcf at 4 ºC.

tology, tissue samples were dehydrated in an increasing gradient of

Flow cytometry: Single-cell preparations were used for flow

ethanol and embedded in paraffin. Five-µm sections were cut and

cytometric analysis. Antibodies used were as follows: anti-mouse

de-waxed and rehydrated in an ethanol gradient. Sections were

CD45 (CD45-APC-Cy7—cat. 103116, clone 30-F11, LOT B185138,

stained with haematoxylin and eosin (H&E) and Picrosirius Red. All

dilution 1:800), anti-mouse CD3 (CD3-APC—cat. 100235, clone

reagents were purchased from Sigma-Aldrich (Sigma-Aldrich, Dorset,

17A2, LOT B166471, dilution 1:200), anti-mouse CD4 (CD4-FITC—

UK). Semi-quantitative scoring of heart sections was performed as

cat. 115505, clone 6D5, LOT B131781, dilution 1:200), anti-mouse

established previously.30 H&E-stained sections were used to analyse

CD8a (CD8a-PE—cat. 101207, clone M1/70, LOT B166034, dilution

and score immunopathology. Picrosirius Red staining was used to

1:400), anti-mouse CD62L (CD62L-AP—cat. 137607, clone 29A1.4,

analyse and score fibrosis. Individual parameters were scored on a

LOT B152186, dilution 1:200) and anti-mouse CD44 (CD44-APC—

scale of 0 (none), 1 (mild), 2 (moderate) to 3 (severe). Scores were

cat. 137607, clone 29A1.4, LOT B152186, dilution 1:200). All were

obtained from 4 areas each on 2 midline cross sections per animal

purchased from BioLegend (BioLegend, London, UK). Antibody dilu-

by a blinded researcher. Images were captured using a Hamamatsu

tions in cell staining buffer containing 1% TruStain fcX™ (antimouse

NanoZoomer 2.0 slide scanner (Hamamatsu, San Jose, CA, US) and a

CD16/32) antibody (both from BioLegend, London, UK) were used

LMD7000 microscope (Leica microsystems, Milton Keynes, UK) and

to stain according to the manufacturer's protocol. Samples were ac-

processed for quantification of nuclei (cell count) and area of fibro-

quired using a BD LSRII (Becton Dickinson, Oxford, UK) and analysed

sis using NDP.view2 Plus Image viewing software (Hamamatsu, San

using FlowJo version 10.6.1 software (Tree Star, Ashland, OR, USA).31

232

|

FORTE et al.

Immunohistochemistry: For the detection of in vivo antibody

mice recovered within a few hours as judged by the return of normal

deposition in cardiac tissue, 5-µm sections of frozen post-isoprotere-

feeding and grooming behaviour and were expected to not show any

nol hearts were stained with goat anti-mouse IgG-FITC (cat. F5387,

more clinical signs of treatment after 24h. Mortality was rare (cumu-

Sigma-Aldrich, Dorset, UK) and rat anti-mouse IgM-PE (cat. 406507,

lative mortality over a year was estimated to be below 1%), occurs

BioLegend, London, UK). Images were captured using a LMD7000 mi-

within the first day and is presumably because of acute arrhythmic

croscope (Leica microsystems, Milton Keynes, UK) and processed using

problems. 80 and 160mg/kg isoproterenol induced significant in-

the public domain software ImageJ (NIH; http://rsb.info.nih.gov).

crease in cardiac troponin I (cTnI) in the serum 24h after injection

Experimental planning and statistical analysis: Individual animals

(Figure 1A). cTnI is the current gold standard clinical biomarker for

were randomly allocated to experimental groups from a homoge-

myocardial necrosis and allows detection of T2MI in the absence of

neous age- and sex-matched pool, husbandry and care was provided

CAD.6,37

by blinded staff, and analysis was performed by a blinded researcher.

80 and 160mg/kg isoproterenol also increased myocardial in-

Initial exploratory titration experiments used n = 3 for welfare rea-

filtration and fibrosis 2 weeks after injection (Figure 1B). Spleen/

sons. Subsequent experimental group sizes were defined based on

bodyweight ratio as a measure of systemic inflammation and body-

the effect size of 3.8 achieved in infiltration scoring experiments.

weight as indicator of overall health were not affected with doses up

To achieve 95% power, with 0.05 set as alpha error, a group size of

to 160mg/kg (Figure 1C, D). 160mg/kg each on 2 subsequent days

3 is necessary for the primary readouts of infiltration. Smaller ef-

however increased spleen/bodyweight ratio and reduced body-

fect sizes were expected and accepted as biologically significant for

weight. A single injection of 160mg/kg was thus chosen as standard

flow cytometry, MRI and ELISA results; thus, group sizes were in-

dose for subsequent experiments. Histopathological analysis of the

creased for these experiments. Statistical analysis was performed

hearts showed tissue damage resulting in granulation tissue and fi-

using GraphPad Prism 8, and data were presented as mean ± s.e.m

brosis. Consistent with catecholaminergic damage, injury was most

throughout. Normal distribution of parametric data was tested using

prominent in the sub-endocardium (Figure 1E).

Shapiro-Wilk test. Comparison between 2 groups was performed
using Student's t test with Welch's correction to account for possible differences in variation between control and treatment group.
Comparison between multiple experimental groups was performed

3.2 | Off-target histopathology in kidney, liver,
lung and skeletal muscle is negligible

using one- or two-way ANOVA with Dunnett's multiple comparisons
post hoc test to obtain multiplicity-adjusted p-values. Scoring data

To define the degree of off-target damage to other organs, we per-

were analysed using non-parametric Kruskal-Wallis test with Dunn's

formed a thorough histopathological assessment of kidneys, liver,

multiple comparisons post hoc test to obtain multiplicity-adjusted

lung and skeletal muscle at weeks 1 and 2 after injection of 160mg/

p-values. Differences were considered significant at P < .05.

kg isoproterenol. Myocardial infiltration and fibrosis were confirmed
(Figure 2A). No pathological changes were observed in the other

3 | R E S U LT S
3.1 | A single dose of isoproterenol induces cardiac
histopathology reminiscent of human type-2 MI in
C57BL/6J mice

tested organs in any of the mice (n = 5/group) at week 1 (Figure 2B,
C, S1). Although isoproterenol has been shown previously to induce
acute necrosis in skeletal myocytes,38 the regenerative ability of
skeletal muscle 39 appears to allow it to restore healthy morphology
by week 1. At week 2, mild acute tubular injury and fibrosis were
detectable in the kidneys (Figure 2B, C, S1). This thus happened after
established cardiac damage. Renal damage has been documented as

Isoproterenol induces cardiomyocyte necrosis with necrotic car-

secondary to cardiac damage after experimental surgical LAD liga-

diomyocytes mostly localised in the sub-endocardium.33 Different

tion

mouse strains show variable susceptibility to induction of cardiac

injury and fibrosis was therefore broadly consistent with the estab-

damage, and C57BL/6J mice have a robust cardiac phenotype rel-

lished concept of cardiorenal syndrome, which is renal damage/dys-

atively resistant to myocardial fibrosis.34,35,36 They are however

function due to cardiac damage/dysfunction, and vice versa.42

40

and in human MI patients.41 The observed pattern of renal

among the best characterised mouse strains and commonly used
for genetic modification and immunological studies. To allow subsequent use of this common mouse strain, we performed a dose
titration experiment to investigate whether C57BL/6J mice were
susceptible to developing cardiac lesions while maintaining high

3.3 | A single dose of 160mg/kg isoproterenol
induces cardiac dilation and impairs systolic function
in C57BL/6J mice

animal welfare standards. Male C57BL/6J mice were treated with
a single bolus intra-peritoneal injection of increasing doses of iso-

To assess whether immunopathology observed by histology was

proterenol starting with 40mg/kg up to 160mg/kg. Isoproterenol

severe enough to affect cardiac morphology and function, we

effects were evident from 15 minutes after injection, when mice

performed cardiac magnetic resonance (CMR) imaging before and

ceased moving and increased respiration rates were observed. Most

2 weeks after isoproterenol injection. Previous studies using variable

FORTE et al.
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F I G U R E 1 A single high dose of isoproterenol induces myocardial inflammation and fibrosis in C57BL/6J mice. Male C57BL/6J mice were
treated with a single increasing dose of isoproterenol to induce myocardial ischaemia and cardiomyocyte necrosis and analysed 2 weeks
after challenge. A, Serum cardiac troponin I (cTroponin I) levels to confirm myocardial injury. B, Infiltration and fibrosis were scored on a
scale from 0 to 3 (none, mild, moderate, severe) in 4 fields of view in 2 heart cross sections at mid-level per mouse. C, Splenomegaly (spleen/
bodyweight ratio) as a measure of systemic immune activation. D, Change in bodyweight. E, Micrographs of H&E- and Picrosirius Red–
stained paraffin-embedded cross sections of the hearts showing mononuclear cell infiltration (H&E) and interstitial fibrosis (Picrosirius Red).
Data are expressed as mean ± s.e.m., *P < .05, **P < .001, ***P < .0001 (B: non-parametric Kruskal-Wallis with Dunn's multiple comparisons
post hoc test comparing each time-point to baseline. A, C and D: one-way ANOVA with Dunnett's multiple comparisons post hoc test
comparing each time-point to baseline)
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F I G U R E 2 A single high dose of isoproterenol does not affect liver, lung and skeletal muscle, but pathological changes in the kidneys
are observed secondary to cardiac damage at week 2. Male C57BL/6J mice were treated with a single dose of isoproterenol to induce
myocardial ischaemia and cardiomyocyte necrosis. A, Myocardial infiltration and fibrosis were scored on a scale from 0 to 3 (none, mild,
moderate, severe) in 4 fields of view in 2 heart cross sections at mid-level per mouse. B, Kidney fibrosis was scored on a scale from 0 to
3 (none, mild, moderate, severe) in 4 fields of view in 2 cross sections per mouse. n = 5/group, symbols represent individual mice. Data
are expressed as mean ± s.e.m., *P < .05 (non-parametric Kruskal-Wallis with Dunn's multiple comparisons post hoc test comparing each
time-point to baseline). C, Micrographs of H&E- and Picrosirius Red–stained paraffin-embedded sections of post-isoproterenol organs for
assessment of mononuclear cell infiltration (H&E) and interstitial fibrosis (Picrosirius Red). Representative image shown

F I G U R E 3 Isoproterenol treatment causes significant volumetric changes in the heart and impaired systolic function. Male C57BL/6J
mice were treated with a single dose of isoproterenol and analysed for cardiac morphology and function before and 2 weeks after
isoproterenol challenge. A, Representative long-axis views (HLA and VLA) required for accurate planning of multi-stack short-axis CINE
slices (grey lines). Each cardiac image was segmented at end diastole and end systole from base to apex to derive the outer and inner border
of the left ventricle (LV) required for LV end-diastolic volume (EDV), LV end-systolic volume (ESV), LV ejection fraction (EF) and LV mass
assessment. B, Quantification of LV EF pre- and 2 weeks post-isoproterenol administration. C, Representative images of end-systolic and
end-diastolic hearts pre- and 2 weeks post-isoproterenol administration D, Quantification of LV EDV, ESV and mass pre- and 2 weeks postisoproterenol administration. n = 6/group, symbols represent individual mice before and after isoproterenol treatment. Values represent
mean ± s.e.m.; *P < .05, **P < .005, one-tailed, paired Student's t test
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ventricular (LV) ejection fraction (Figure 3B) was detectable 2 weeks
after isoproterenol treatment. This was paralleled by an increase in
LV end-diastolic and end-systolic volumes (Figure 3D) suggestive of
LV dilation. Isoproterenol administration did not cause significant alteration of LV mass by week 2 after treatment (Figure 3D).

3.4 | Model refinement and reduction in
animal numbers
By convention, our first set of experiments was performed in male
mice. However, considering a female dominance in autoimmune disease, immunological research is often performed in female mice. To
reduce the number of surplus animals and ensure relevance to both
sexes,44 we compared histology in isoproterenol-injected male and
female mice. Results showed an equivalent level of cardiac histopathology (Figure 4A, B) which allowed the use of female mice in subsequent immunological experiments and will also support the use of
both sexes in the future.
To further improve animal welfare benefits of the isoproterenol model, we included pre-treatment with 0.05mg/kg buprenorphine for pain relief. Buprenorphine was injected subcutaneously
30 minutes before isoproterenol administration. Manual mouse
grimace scale (MGS) scoring was deemed not suitable, as no orbital tightening, or changes in nose and cheek bulge and whisker
position were notable.45 Instead, we measured activity (moving,
feeding, drinking, grooming) as a reliable sign of both the onset
of and the recovery from acute isoproterenol effects (Figure 4C).
Adding buprenorphine to the isoproterenol treatment shortened
the average time to recovery by 20 minutes without affecting the
F I G U R E 4 Opportunities for refinement and reduction in the
isoproterenol-induced T2MI model. Male and female C57BL/6J
mice were treated with a single dose of isoproterenol to induce
myocardial ischaemia and cardiomyocyte necrosis. A, B, Myocardial
infiltration (A) and fibrosis (B) were scored on a scale from 0 to
3 (none, mild, moderate, severe) in 4 fields of view in 2 heart
cross sections at mid-level per mouse. n = 3-5/group, symbols
represent individual mice. C, D, Female C57BL/6J mice were
treated with a single dose of isoproterenol with and without
0.05mg/kg buprenorphine to induce myocardial ischaemia and
cardiomyocyte necrosis under analgesia. C, Count of animals with
normal movement and activity and average time until recovery
of normal activity pattern. D, Infiltration and fibrosis in cardiac
tissue sections 2 weeks after isoproterenol injection. n = 3/group,
symbols represent individual mice. Histopathology scoring data are
expressed as mean ± s.e.m., *P < .05 (A, B: two-way ANOVA with
Sidak's multiple comparison post hoc test comparing each group to
each other. D: non-parametric Kruskal-Wallis with Dunn's multiple
comparisons post hoc test comparing each time-point to baseline)

degree of cardiac inflammatory and fibrotic damage (Figure 4D).

3.5 | A single high dose of isoproterenol triggers
dendritic cell (DC) accumulation in the heart
Isoproterenol-induced cardiomyocyte damage leads to necrotic cell
death,33 a potent trigger of innate immune responses initiating a classical wound healing response to remove cellular debris and restore
tissue integrity.46 To investigate the composition of the myocardial
immune cell infiltrate, we performed flow cytometry on single-cell
suspensions of ventricular tissue 1 and 2 weeks after isoproterenol
treatment (Figure 5A). As expected, the CD45+ myocardial immune
cell population was increased 1 week after isoproterenol injection and
was largely composed of myeloid cells, whereas total numbers of adaptive CD19+ B and CD3+ T lymphocytes remained stable (Figure 5B).
Dendritic cells are crucial in the induction of adaptive immune
responses and autoimmunity because of their unique ability of ac-

dosing regimens reported morphological changes and diastolic dysfunction.

24,34,43

tivating antigen-specific CD4+ helper T cells.47 Their numbers peak

After planning of vertical long-axis (VLA) and hori-

1 week after ischaemic damage induced by surgical LAD ligation in

zontal long-axis (HLA) cardiac views (Figure 3A), the endocardial and

mice.48 Numbers of CD11c+ DC were significantly increased after

epicardial borders were contoured from apex to base at end-diastole

1 week in isoproterenol-treated hearts, confirming this timing in the

and end-systole phases (Figure 3C). A mild but significant drop in left

isoproterenol model. Importantly, increased DC number is the first
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F I G U R E 5 Myocardial CD45+ immune cell infiltrate in response to a single dose of 160mg/kg isoproterenol. Female C57BL/6J mice were
treated with a single dose of isoproterenol to induce myocardial ischaemia and cardiomyocyte necrosis, and flow cytometry was performed
on single-cell preparations of heart ventricles 1 and 2 weeks after isoproterenol injection. A, Representative dot plots showing the flow
cytometry gating strategy to obtain total CD45+, CD3+, CD19+, CD11b+ and CD11c+ populations. B, Quantification of the total number of
CD45+, CD3+, CD19+, CD11b+ and CD11c+ cells per mg ventricular tissue in isoproterenol-treated versus control mice. n = 8/group, symbols
represent individual mice. C, Quantification of the fraction of CD4+ T cells among total T cells in the ventricular tissue of isoproterenol-treated
versus control mice. D, Representative contour plots of CD62L and CD44 staining of CD3+ CD4+ T cells and corresponding quantification of
the CD62L-CD44- subpopulation of effector T cells in isoproterenol-treated versus control mice. n = 4-5/group, symbols represent individual
mice. Data are expressed as mean ± s.e.m., *P < .001, **P < .05, ****P < .0001 (B: one-way ANOVA with Dunnett's multiple comparisons post
hoc test comparing each time-point to baseline. C, D: one-tailed unpaired Student's t test with Welch's correction)

step towards the induction of an adaptive immune response and au-

adaptive immune response, we performed a refined analysis of the

toimmunity against the heart.

myocardial CD4+ T cell phenotype by staining for the surface markers
CD44 and CD62L which allow distinction between effector and naïve T

3.6 | Myocardial CD4+ helper T cells are activated
in response to a single high dose of isoproterenol

cells. Although the total fraction of CD4+ T cells remained unchanged
(Figure 5C), an increase in activated CD62L-CD44- effector cells is apparent (Figure 5D). We also find activated CD4+ T cells in the mediastinal
lymph nodes of male mice (Figure S2) showing relevance of these pro-

To investigate whether early DC activation in response to isoproterenol-

cesses for both sexes. This confirms persistent activation of the adaptive

induced cardiomyocyte necrosis is sufficient to trigger a downstream

immune system in response to isoproterenol-induced myocardial injury.
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3.7 | Isoproterenol treatment triggers the
production and in vivo deposition of mature antiheart auto-antibodies

A recent report shows that splenic T cells isolated from C57BL/6

Activated autoreactive CD4+ helper T cells induce B cells to generate

proterenol-induced T2MI, we performed an adoptive transfer of

mature auto-antibodies, which are a hallmark sign of an established

total splenocytes, splenic CD4+ T cells (T cell–mediated damage) or

autoimmune response. We found a significant amount of mature IgG

serum (auto-antibody mediated damage) from isoproterenol-treated

deposited in the myocardium 4 weeks after isoproterenol injection

mice 4 weeks post-injection, to healthy syngeneic recipients.

(Figure 6A, B). The linear deposition pattern followed the myocyte

Splenocytes were used because of the obtainable numbers and after

fibres and the inner lining of blood vessels. In particular, vessels sur-

confirmation that an increase in the CD44-CD62L- effector subpop-

rounded by perivascular infiltrate appeared affected. In addition, a

ulation is also observed in splenic CD4+ T cells (Figure 7A).

mice subjected to permanent coronary ligation induce LV remodelling upon transfer into healthy recipient mice.49
To show whether immunopathology is also transferable in iso-

small number of IgG+ cells, presumably mature B cells, were found

A single intravenous transfer of 3x107 splenocytes from iso-

in both baseline and isoproterenol-treated tissue. We further tested

proterenol-treated mice affected global cardiac function as shown

post-isoproterenol serum at week 2 (acute) and week 12 (chronic) for

by a drop in LV ejection fraction 4 weeks after transfer (Figure 7B).

the persistent presence of anti-heart auto-antibodies. We found a

This functional impairment was likely because of impaired contrac-

significant increase in auto-antibody levels at chronic stage after iso-

tility and dilation as LV volumes increased in recipients of isoprotere-

proterenol injection (Figure 6C). Importantly, these auto-antibodies

nol-splenocytes (Figure 7C). Notably, transfer of 1x107 isolated

are of the mature class-switched IgG isotype as present in estab-

CD4+ T cells only partially recapitulated the effects of total sple-

lished and persistent adaptive immune responses.

nocytes and we did not observe any differences between control

This confirms that mature autoreactive B cells persist for an extended period after initial damage and produce class-switched au-

groups and mice treated with serum from isoproterenol-injected
donor mice (Figure 7B, C).

to-antibodies against the heart, which deposit on cardiomyocytes

This confirms that besides acute myocardial necrosis and subse-

and endothelial cells in vivo, which is the prerequisite for auto-anti-

quent fibrotic tissue repair, isoproterenol injection triggers the devel-

body–mediated tissue damage.

opment of long-term autoimmunity capable of inducing heart damage
and affecting cardiac function. This is likely a multi-dimensional pro-

3.8 | Adoptive transfer of splenocytes from
isoproterenol-treated C57BL/6J mice is sufficient to
induce LV dilation and functional decline

cess caused by the interplay between several immune cells and factors.

4 | D I S CU S S I O N

Adoptive transfer of autoreactive immune cells is a well-established

Here, we show that T2MI-like necrotic lesions induced by a single

strategy to prove their pathological effects isolated from potential

high dose of the synthetic catecholamine isoproterenol trigger per-

confounding factors because of the initial experimental challenge.

sistent adaptive immunopathology in the heart (Figure 8)

F I G U R E 6 A single dose of isoproterenol triggers production of anti-heart auto-antibodies. Female C57BL/6J mice were treated with
a single dose of 160mg/kg isoproterenol to induce myocardial ischaemia and cardiomyocyte necrosis, and the heart and serum were
obtained for analysis of anti-heart auto-antibody production. A, Quantification of mean fluorescence intensity (MFI). B, Example image of
immunofluorescence staining of frozen heart sections of isoproterenol-treated mice 4 weeks after challenge, using goat anti-mouse IgGFITC and rat anti-mouse IgM-PE to detect in vivo deposits of anti-heart auto-antibodies, green: IgG, red: IgM, blue: DAPI (nuclei). n = 4-9/
group. C, Levels of anti-cardiac auto-antibodies in the serum over time as tested by ELISA using serum of isoproterenol-treated mice against
rat cardiac lysate. n = 5-6/group, symbols represent individual mice. Data are expressed as mean ± s.e.m., **P < .001, ****P < .0001 (oneway ANOVA with Dunnett's multiple comparisons post hoc test comparing each time-point to baseline)
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F I G U R E 7 Adoptive transfer of splenocytes from isoproterenol-injected donor mice leads to LV dilation and impairs cardiac function.
Female donor C57BL/6J mice were treated with a single dose of isoproterenol to induce myocardial ischaemia and cardiomyocyte necrosis.
Serum was collected and splenocytes and CD4+ T cells isolated after 4 weeks. A, Representative contour plots of CD62L and CD44 staining
of splenic CD3+ CD4+ T cells and corresponding quantification of the CD62L-CD44- subpopulation of effector T cells in isoproterenoltreated versus control mice. n = 4-5/group, symbols represent individual mice. Recipient mice were treated with an intravenous injection of
3x107 control (ctrl-spleno) or ISO-splenocytes (ISO-spleno), 1x107 ISO-T cells or a twice-weekly intraperitoneal injection of 200ul ISO-serum
for 2 weeks. B, C, Echocardiography to assess global LV function (LV ejection fraction, B) and heart morphology (end-systolic and enddiastolic volumes, C) was performed after 4 weeks. Data are expressed as mean ± s.e.m., *P < .001, **P < .05, ****P < .0001 (A: one-tailed
unpaired Student's t test with Welch's correction. B, C: one-way ANOVA with Dunnett's multiple comparisons post hoc test comparing each
group to ctrl-spleen)

F I G U R E 8 Isoproterenol-induced
cardiomyocyte necrosis leads to the
passive release of alarmins and antigens
including cardiac troponin I, which is used
as serum biomarker for cardiac damage.
Pro-inflammatory alarmins trigger acute
innate immune cell infiltration including
DC at week 1 after isoproterenol
challenge. Interstitial fibrosis and
morphological and functional changes
are also observed at this time. Myocardial
DC activate auto-reactive effector T cells
in the mediastinal lymph nodes. Effector
T cells in turn induce B cells to generate
mature auto-antibodies that deposit along
myocardial fibers.
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The definition of myocardial infarction differentiates patients
with MI because of coronary occlusion and plaque rupture (T1MI)
from those with myocardial necrosis because of oxygen sup-

ischaemic damage. Both autoreactive B and T cells have been detected after myocardial damage in mouse models
patients.

62,63

and human

64,65

ply-demand imbalance (T2MI). 50,51 Myocardial necrosis without

We show here that isoproterenol-induced myocardial necrosis

symptoms or signs of myocardial ischaemia is classified as acute

triggers dendritic cell expansion in the myocardium and T cell acti-

or chronic myocardial injury. Both myocardial injury and T2MI

vation in the mediastinal lymph nodes. Activated T cells stimulate B

are common, yet these patients have poor short-term and long-

cells to produce mature IgG anti-heart auto-antibodies against the

with a heart failure risk comparable to T1MI. 8

heart, a sign of a bona fide autoimmune response. Importantly, we

Injection of a single high dose of isoproterenol mimics an exces-

confirm cell-mediated immunopathology against the heart by adop-

sive activation of the adrenergic system and leads to sympathetic

tive transfer of splenocytes from T2MI mice.

term outcome

7,51

overstimulation of the heart. This can be observed during critical illness in human patients
syndrome

53,54

52

including those with takotsubo

and in septic patients

55

or those receiving cate-

Anti-heart auto-antibodies indicating autoimmunity have thus
far been demonstrated in a wide range of human heart conditions
66

and are likely because of high amounts of cardiac antigen in an

cholamines for cardiac pacing or inotropic support. Detrimental

inflammatory environment overwhelming immunological tolerance.

effects of excess catecholamines on the heart include impaired

Importantly, the adaptive immune system is activated by antigens

diastolic function, tachycardia and tachyarrhythmia. 52 The conse-

released from necrotic cells irrespective of the initial cause of necro-

quent imbalance between myocardial oxygen supply and demand,

sis. Accordingly, we found anti-heart auto-antibodies in experimen-

dysregulation of calcium handling and the resulting degree and

tal models after surgical induction of T1MI via LAD ligation
30

16

and

pattern of myocardial necrosis, inflammatory infiltration and re-

under systemic inflammatory conditions,

placement fibrosis are reminiscent of the myocardial damage in-

study after chemical induction of T2MI-like myocardial necrosis.

curred by human T2MI. Notably, the autonomous nervous system

The common factor in these situations is myocardial necrosis, which

and aberrant adrenergic stimulation of the heart have also been

is sufficient to induce a downstream adaptive immune response

suggested as a clinically targetable pathological factor after myo-

against the heart.

cardial infarction 56 and in the development of heart failure. 57,58

as well as in the present

Autoimmunity against the heart causes persistent myocar-

Concerns about off-target damage to other organs have pre-

dial immunopathology and ongoing tissue degeneration, which

viously hampered acceptance of the isoproterenol model. Using

exacerbates development towards heart failure. 67 Underlying

our treatment regimen, these appear uncalled-for as no direct iso-

pathological mechanisms are still far from understood, but the

proterenol-induced pathological changes were observed in liver,

isoproterenol model provides an opportunity to study these pro-

lung and skeletal muscle. Damage to the kidneys was of particular in-

cesses in T2MI-like heart disease. Simplicity and resource effi-

terest as there are a range of isoproterenol-activated pathways that

ciency will allow thorough investigation of a range of aspects that

may sensibly be assumed to cause kidney injury. For example, iso-

likely affect short- and long-term outcome in T2MI patients in-

proterenol-induced activation of the renin-angiotensin cascade may

cluding investigation of (a) the local innate immune response in

lead to liberation of angiotensin II,59 which can cause renal vaso-

the myocardium, (b) the role of lymphatics and fibroblasts in post-

constriction driving ischaemia and fluid overload and promotes renal

T2MI autoimmunity, 68,69 (c) the influence of genetics on the risk of

oxidative stress, inflammation and fibrosis.

60

However, because of

belated onset, the mild acute tubular injury and fibrosis detected in

developing heart failure after T2MI 34 and (d) how all of the above
can be targeted for improved therapeutics.

the kidneys 2 weeks after treatment are most consistent with cardiorenal syndrome, a positive feedback loop in which a damaged
heart leads to renally mediated fluid retention, which then further

4.1 | Study limitations

aggravates the underlying heart dysfunction.42
The immune response following myocardial injury has received

Immune cells express adrenoreceptors,70,71 and long-term isopro-

significant attention recently. It is initiated by the release of dan-

terenol treatment regimens increase circulating immune cells.72

ger-associated molecular patterns (DAMPs) from necrotic cardio-

Because of an in vivo half-life of less than 5 minutes, the effects of a

myocytes, which activates a highly orchestrated innate immune

single acute isoproterenol injection are expected to have worn off by

reaction

46

for the quick removal of necrotic debris and restoration

the time cardiomyocytes develop necrosis and the immune system is

of tissue integrity. The interplay between innate immune cells and

recruited.73 However, an effect on the early immune response can-

fibroblast plays a crucial role in the ensuing scar formation. Although

not be fully excluded and should be considered when studying very

this immediate wound healing response is critical for acute sur-

early responses.74

vival, the heart appears susceptible to persistent immunopathology

Our adoptive transfer experiment indicates a role of CD4+ T

presumably because of an adaptive autoimmune response against

cells in cardiac immunopathology, but as expected they are not

cardiac antigens including most prominently cardiac myosin.61 This

the sole pathogenic factor. Serum transfer (to test the role of

anti-heart autoimmune response has recently become the focus

circulating auto-antibodies) failed to induce a cardiac phenotype

of studies into how the immune system affects the heart after

which may have several technical (eg insufficient amount of serum
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transferred) and/or biological reasons (e.g. majority of anti-heart

AU T H O R C O N T R I B U T I O N S

auto-antibodies are bound to donor myocardium, 4 weeks are not
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The decline of global cardiac function we observed in this study
in C57BL/6J mice was significant but mild compared to clinical defi-
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nol-induced T2MI and other types of cardiac damage such as LAD
ligation-induced T1MI or experimental autoimmune myocarditis and
is worth exploring further.78
Several additional factors that might affect the response to isoproterenol treatment have not been investigated systematically including age and potential age-dependent sex differences, circadian
rhythm and seasonality, as well as holding conditions (e.g. SPF versus
conventional animal facility affecting microbiome).
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